These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 20222801)

  • 1. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth.
    Luo Z; Zang M; Guo W
    Future Oncol; 2010 Mar; 6(3):457-70. PubMed ID: 20222801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting AMPK for cancer prevention and treatment.
    Li W; Saud SM; Young MR; Chen G; Hua B
    Oncotarget; 2015 Apr; 6(10):7365-78. PubMed ID: 25812084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LKB1; linking cell structure and tumor suppression.
    Hezel AF; Bardeesy N
    Oncogene; 2008 Nov; 27(55):6908-19. PubMed ID: 19029933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator.
    Faubert B; Vincent EE; Poffenberger MC; Jones RG
    Cancer Lett; 2015 Jan; 356(2 Pt A):165-70. PubMed ID: 24486219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK, the metabolic syndrome and cancer.
    Luo Z; Saha AK; Xiang X; Ruderman NB
    Trends Pharmacol Sci; 2005 Feb; 26(2):69-76. PubMed ID: 15681023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation.
    Hou X; Liu JE; Liu W; Liu CY; Liu ZY; Sun ZY
    Oncogene; 2011 Jun; 30(26):2933-42. PubMed ID: 21317932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Pyridones As Oral AMPK Direct Activators.
    Mirguet O; Sautet S; Clément CA; Toum J; Donche F; Marques C; Rondet E; Pizzonero M; Beaufils B; Dudit Y; Huet P; Trottet L; Grondin P; Brusq JM; Boursier E; Saintillan Y; Nicodeme E
    ACS Med Chem Lett; 2013 Jul; 4(7):632-6. PubMed ID: 24900722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of AMP-activated protein kinase in cancer therapy.
    Rehman G; Shehzad A; Khan AL; Hamayun M
    Arch Pharm (Weinheim); 2014 Jul; 347(7):457-68. PubMed ID: 24677093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine monophosphate-activated kinase and its key role in catabolism: structure, regulation, biological activity, and pharmacological activation.
    Krishan S; Richardson DR; Sahni S
    Mol Pharmacol; 2015; 87(3):363-77. PubMed ID: 25422142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism.
    Jansen M; Ten Klooster JP; Offerhaus GJ; Clevers H
    Physiol Rev; 2009 Jul; 89(3):777-98. PubMed ID: 19584313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LKB1/AMPK polarity pathway.
    Mirouse V; Billaud M
    FEBS Lett; 2011 Apr; 585(7):981-5. PubMed ID: 21185289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice.
    Noda K; Nakajima S; Godo S; Saito H; Ikeda S; Shimizu T; Enkhjargal B; Fukumoto Y; Tsukita S; Yamada T; Katagiri H; Shimokawa H
    PLoS One; 2014; 9(11):e110446. PubMed ID: 25365359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK activators--potential therapeutics for metabolic and other diseases.
    Zhou G; Sebhat IK; Zhang BB
    Acta Physiol (Oxf); 2009 May; 196(1):175-90. PubMed ID: 19245659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK-dependent hormonal regulation of whole-body energy metabolism.
    Dzamko NL; Steinberg GR
    Acta Physiol (Oxf); 2009 May; 196(1):115-27. PubMed ID: 19245657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo.
    Algire C; Amrein L; Bazile M; David S; Zakikhani M; Pollak M
    Oncogene; 2011 Mar; 30(10):1174-82. PubMed ID: 21102522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
    Dowling RJ; Zakikhani M; Fantus IG; Pollak M; Sonenberg N
    Cancer Res; 2007 Nov; 67(22):10804-12. PubMed ID: 18006825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of AMPK and p53 dependent signaling to radiation response in the presence of metformin.
    Muaddi H; Chowdhury S; Vellanki R; Zamiara P; Koritzinsky M
    Radiother Oncol; 2013 Sep; 108(3):446-50. PubMed ID: 23891087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPK as a mediator of hormonal signalling.
    Lim CT; Kola B; Korbonits M
    J Mol Endocrinol; 2010 Feb; 44(2):87-97. PubMed ID: 19625456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK: Therapeutic Target for Diabetes and Cancer Prevention.
    Umezawa S; Higurashi T; Nakajima A
    Curr Pharm Des; 2017; 23(25):3629-3644. PubMed ID: 28714409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.